NJ A5101 | 2018-2019 | Regular Session
Note: Carry Foward to future A277
Note: Carry Foward to future S2035
Note: Carry Foward to future S2035
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on March 5 2019 - 25% progression, died in committee
Action: 2019-03-05 - Introduced, Referred to Assembly Health and Senior Services Committee
Pending: Assembly Health and Senior Services Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on March 5 2019 - 25% progression, died in committee
Action: 2019-03-05 - Introduced, Referred to Assembly Health and Senior Services Committee
Pending: Assembly Health and Senior Services Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical manufacturers.
Title
Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical manufacturers.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2019-03-05 | Assembly | Introduced, Referred to Assembly Health and Senior Services Committee |
Same As/Similar To
A5101 (Carry Over) 2019-03-05 - Introduced, Referred to Assembly Health and Senior Services Committee
A5101 (Carry Over) 2019-03-05 - Introduced, Referred to Assembly Health and Senior Services Committee
S3336 (Same As) 2019-01-17 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
A5101 (Carry Over) 2019-03-05 - Introduced, Referred to Assembly Health and Senior Services Committee
S3336 (Same As) 2019-01-17 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Subjects
New Jersey State Sources
Type | Source |
---|---|
Summary | https://www.njleg.state.nj.us/bill-search/2018/A5101 |
Text | https://pub.njleg.gov/Bills/2018/A9999/5101_I1.HTM |